164 related articles for article (PubMed ID: 3495542)
1. Fibronectin-associated transforming growth factor.
Fava RA; McClure DB
J Cell Physiol; 1987 May; 131(2):184-9. PubMed ID: 3495542
[TBL] [Abstract][Full Text] [Related]
2. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
3. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
4. Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae.
Centrella M; Canalis E
J Bone Miner Res; 1987 Feb; 2(1):29-36. PubMed ID: 3502665
[TBL] [Abstract][Full Text] [Related]
5. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
Jullien P; Berg TM; de Lannoy C; Lawrence DA
J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
7. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
Rizzino A; Ruff E; Rizzino H
Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of anchorage-independent cell growth by endothelin in NRK 49F cells.
Kusuhara M; Yamaguchi K; Kuranami M; Suzaki A; Ishikawa S; Moon H; Adachi I; Hori S; Handa S
Cancer Res; 1992 Jun; 52(11):3011-4. PubMed ID: 1317255
[TBL] [Abstract][Full Text] [Related]
9. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
10. [A transforming growth factor-beta like growth factor in mouse embryonal carcinoma cells].
Shi WK; Yao Z
Shi Yan Sheng Wu Xue Bao; 1989 Jun; 22(2):213-23. PubMed ID: 2800839
[TBL] [Abstract][Full Text] [Related]
11. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
Newman MJ; Lane EA; Nugent MA; Racker E
Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
[TBL] [Abstract][Full Text] [Related]
12. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 binds to immobilized fibronectin.
Mooradian DL; Lucas RC; Weatherbee JA; Furcht LT
J Cell Biochem; 1989 Dec; 41(4):189-200. PubMed ID: 2625433
[TBL] [Abstract][Full Text] [Related]
14. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma.
Saulnier R; Bhardwaj B; Klassen J; Leopold D; Rahimi N; Tremblay E; Mosher D; Elliott B
Exp Cell Res; 1996 Feb; 222(2):360-9. PubMed ID: 8598224
[TBL] [Abstract][Full Text] [Related]
16. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
Rijksen G; Völler MC; Van Zoelen EJ
J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of 25Kd fibronectin-binding growth factor.
Eskandarani HA; Ayad SR
Anticancer Res; 1989; 9(3):695-707. PubMed ID: 2788387
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor production by chemically transformed cells.
Moses HL; Branum EL; Proper JA; Robinson RA
Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF)-like transforming growth factor (TGF) activity and EGF receptors in ovine fetal tissues: possible role for TGF in ovine fetal development.
Freemark M; Comer M
Pediatr Res; 1987 Nov; 22(5):609-15. PubMed ID: 3500450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
